View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Polatuzumab Vedotin 1.8 / Mosunetuzumab (1/2/60), diffuse large B-Non-Hodgkin Lymphoma, cycle 1
Protocol-ID: 2812 V1.0 (Mini), POLVED1.8/MOSU(1/2/60), DLBCL, C1Indication(s)
- NHL, B-Cell Type, Diffuse Large Cell; ICD-10 C83.3
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 01.03.2025